Jeremy Bash· Business · 10 sources · Sep 15, 2026StoryLegend Biotech names Novartis executive Ingrid Zhang CEOLegend Biotech appointed Ingrid Zhang as Chief Executive Officer, effective September 15, 2026, with interim CEO Alan Bash becoming President of CARVYKTI. Zhang, a former Novartis executive and China head, brings broad global leadership experience from AstraZeneca, Pfizer, and McKinsey as the board positions Legend for its next growth phase.Business· Sep 15, 2026+7+23ShareTom Gallagher·Sep 15, 2026Top commentHiring someone with McKinsey and AstraZeneca experience signals the board wants tighter global operations going forward.00ReplyGenius replyShareWrite a comment…